- Home
- HUMA vs GEVO Comparison
HUMA vs GEVO Comparison
Compare HUMA & GEVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUMA
- GEVO
- Stock Information
- Founded
- HUMA 2004
- GEVO 2005
- Country
- HUMA United States
- GEVO United States
- Employees
- HUMA N/A
- GEVO N/A
- Industry
- HUMA Biotechnology: Pharmaceutical Preparations
- GEVO Major Chemicals
- Sector
- HUMA Health Care
- GEVO Industrials
- Exchange
- HUMA Nasdaq
- GEVO Nasdaq
- Market Cap
- HUMA 250.2M
- GEVO 418.4M
- IPO Year
- HUMA N/A
- GEVO 2011
- Fundamental
- Price
- HUMA $1.51
- GEVO $1.73
- Analyst Decision
- HUMA Strong Buy
- GEVO Buy
- Analyst Count
- HUMA 8
- GEVO 2
- Target Price
- HUMA $10.88
- GEVO $7.58
- AVG Volume (30 Days)
- HUMA 5.9M
- GEVO 9.4M
- Earning Date
- HUMA 08-11-2025
- GEVO 08-11-2025
- Dividend Yield
- HUMA N/A
- GEVO N/A
- EPS Growth
- HUMA N/A
- GEVO N/A
- EPS
- HUMA N/A
- GEVO N/A
- Revenue
- HUMA $818,000.00
- GEVO $80,187,000.00
- Revenue This Year
- HUMA N/A
- GEVO $909.99
- Revenue Next Year
- HUMA $949.92
- GEVO $22.37
- P/E Ratio
- HUMA N/A
- GEVO N/A
- Revenue Growth
- HUMA N/A
- GEVO 341.75
- 52 Week Low
- HUMA $1.15
- GEVO $0.67
- 52 Week High
- HUMA $6.77
- GEVO $3.39
- Technical
- Relative Strength Index (RSI)
- HUMA 36.87
- GEVO 57.77
- Support Level
- HUMA $1.43
- GEVO $1.54
- Resistance Level
- HUMA $1.67
- GEVO $1.86
- Average True Range (ATR)
- HUMA 0.15
- GEVO 0.14
- MACD
- HUMA -0.01
- GEVO 0.01
- Stochastic Oscillator
- HUMA 23.32
- GEVO 31.15
About HUMA Humacyte Inc.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.
About GEVO Gevo Inc.
Gevo Inc is a renewable chemicals and biofuels company engaged in the development and commercialization of alternatives to petroleum-based products based on isobutanol produced from renewable feedstocks. The operating segments are the Gevo segment, GevoFuels segment, and the GevoRNG segment. By its segments, it is involved in research and development activities related to the future production of SAF, commercial opportunities for other renewable hydrocarbon products and isobutanol, including the development of its biocatalysts, and the produces-pipeline quality methane gas captured from dairy cow manure. The company derives maximum revenue from the GevoRNG segment.